Their findings were released at the 21st Annual Meeting of the International Society of Heart and Lung Transplantation held here April 25th-28th. Recent studies suggest that some blockades adversely affect African-American patients with systolic heart failure. Researchers conducted a retrospective study of 231 patients with systolic heart failure. All were treated with beta-blockers in the heart failure clinic.
Results show that both groups benefited from beta-blocker therapy.
Improvement was noted in both the ejection fraction as well as the NYHA class in patients who were maintained on this therapy. There was no difference between groups when it came to age, use of angiotensin converting enzyme inhibitors or digoxin. Consulting Group Inc. All rights reserved. Please contact us with any comments, problems or bugs. Consulting Group Inc. All rights reserved.